Are you Dr. Ganesan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1400 Holcombe Blvd
Inv Cancer Therapeutics, Md Anderson Cancer Center
Houston, TX 77030Phone+1 713-563-8965Fax+1 713-792-5553
Clinical Trials
- Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes Start of enrollment: 2011 Jan 01
Publications & Presentations
PubMed
- 3 citationsPhase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer.Thejeswar Nakka, Luxitaa Goenka, Biswajit Dubashi, Smita Kayal, Jayanthi Mathaiyan
Medical Oncology. 2022-09-29 - 6 citationsThe collateral damage" of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer."Luxitaa Goenka, Annuja Anandaradje, Tejaeswar Nakka, Smita Kayal, Biswajit Dubashi
Medical Oncology. 2021-09-28 - 3 citationsA modified olanzapine-based anti-emetic regimen for the control of nausea and vomiting in patients receiving weekly cisplatin.Nikita Mehra, Vasanth Christopher, Manikandan Dhanushkodi, Venkatraman Radhakrishnan, Trivadi S. Ganesan
International Journal of Clinical Pharmacy. 2020-03-09
Press Mentions
Prasanth Ganesan, MD, DM, on Olanzapine for Whetting the Appetite During ChemotherapyJune 28th, 2023
